Raras
Buscar doenças, sintomas, genes...
Facomatose pigmento-vascular
ORPHA:2875CID-10 · Q85.8CID-11 · LD2D.YDOENÇA RARA

Nevo melanocítico congênito (NMC) é uma lesão pigmentada da pele, popularmente conhecidas como pinta, mancha ou sinal, causada pela proliferação anormal de melanócitos em determinadas regiões do corpo. O termo "nevo" vem do latim nevus, que significa "marca de nascença", e refere-se a qualquer lesão escura e circunscrita da pele.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Facomatose pigmento-vascular é uma condição rara associada a mutações nos genes GNAQ/GNA11. Caracteriza-se por manchas cutâneas hipopigmentadas e malformações vasculares, podendo cursar com comprometimento cognitivo, convulsões e calcificações cerebrais.

Publicações científicas
116 artigos
Último publicado: 2026 Jun

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
248
pacientes catalogados
Início
Neonatal
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: Q85.8
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
4 sintomas
🧬
Pele e cabelo
3 sintomas
🦴
Ossos e articulações
1 sintomas
😀
Face
1 sintomas
👁️
Olhos
1 sintomas

+ 4 sintomas em outras categorias

Características mais comuns

90%prev.
Malformação arteriovenosa
Muito frequente (99-80%)
90%prev.
Parestesia
Muito frequente (99-80%)
90%prev.
Densidade mineral óssea reduzida
Muito frequente (99-80%)
90%prev.
Manchas cutâneas hipopigmentadas
Muito frequente (99-80%)
90%prev.
Atrofia cortical cerebral
Muito frequente (99-80%)
90%prev.
Nevo flammeus
Muito frequente (99-80%)
14sintomas
Muito frequente (7)
Frequente (5)
Ocasional (2)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 14 características clínicas mais associadas, ordenadas por frequência.

Malformação arteriovenosaArteriovenous malformation
Muito frequente (99-80%)90%
ParestesiaParesthesia
Muito frequente (99-80%)90%
Densidade mineral óssea reduzidaReduced bone mineral density
Muito frequente (99-80%)90%
Manchas cutâneas hipopigmentadasHypopigmented skin patches
Muito frequente (99-80%)90%
Atrofia cortical cerebralCerebral cortical atrophy
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico116PubMed
Últimos 10 anos57publicações
Pico20229 papers
Linha do tempo
2026Hoje · 2026📈 2022Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

2 genes identificados com associação a esta condição. Padrão de herança: Not applicable.

GNAQGuanine nucleotide-binding protein G(q) subunit alphaCandidate gene tested inAltamente restrito
FUNÇÃO

Guanine nucleotide-binding proteins (G proteins) function as transducers downstream of G protein-coupled receptors (GPCRs) in numerous signaling cascades (PubMed:34556863, PubMed:35672283, PubMed:37991948). The alpha chain contains the guanine nucleotide binding site and alternates between an active, GTP-bound state and an inactive, GDP-bound state (PubMed:37991948). Signaling by an activated GPCR promotes GDP release and GTP binding (PubMed:37991948). The alpha subunit has a low GTPase activity

LOCALIZAÇÃO

Cell membraneGolgi apparatusNucleusNucleus membrane

VIAS BIOLÓGICAS (10)
PLC beta mediated eventsG-protein activationADP signalling through P2Y purinoceptor 1G alpha (q) signalling eventsThrombin signalling through proteinase activated receptors (PARs)
MECANISMO DE DOENÇA

Capillary malformations, congenital

A form of vascular malformations that are present from birth, tend to grow with the individual, do not regress spontaneously, and show normal rates of endothelial cell turnover. Capillary malformations are distinct from capillary hemangiomas, which are highly proliferative lesions that appear shortly after birth and show rapid growth, slow involution, and endothelial hypercellularity.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
54.7 TPM
Brain Frontal Cortex BA9
54.1 TPM
Brain Spinal cord cervical c-1
53.3 TPM
Pulmão
51.6 TPM
Aorta
48.3 TPM
OUTRAS DOENÇAS (5)
Sturge-Weber syndromefamilial multiple nevi flammeianastomosing haemangiomauveal melanoma
HGNC:4390UniProt:P50148
GNA11Guanine nucleotide-binding protein subunit alpha-11Candidate gene tested inAltamente restrito
FUNÇÃO

Guanine nucleotide-binding proteins (G proteins) function as transducers downstream of G protein-coupled receptors (GPCRs) in numerous signaling cascades (PubMed:31073061). The alpha chain contains the guanine nucleotide binding site and alternates between an active, GTP-bound state and an inactive, GDP-bound state (PubMed:31073061). Signaling by an activated GPCR promotes GDP release and GTP binding (PubMed:31073061). The alpha subunit has a low GTPase activity that converts bound GTP to GDP, t

LOCALIZAÇÃO

Cell membraneCytoplasm

VIAS BIOLÓGICAS (10)
PLC beta mediated eventsG-protein activationADP signalling through P2Y purinoceptor 1G alpha (q) signalling eventsThrombin signalling through proteinase activated receptors (PARs)
MECANISMO DE DOENÇA

Hypocalciuric hypercalcemia, familial 2

A form of hypocalciuric hypercalcemia, a disorder of mineral homeostasis that is transmitted as an autosomal dominant trait with a high degree of penetrance. It is characterized biochemically by lifelong elevation of serum calcium concentrations and is associated with inappropriately low urinary calcium excretion and a normal or mildly elevated circulating parathyroid hormone level. Hypermagnesemia is typically present. Affected individuals are usually asymptomatic and the disorder is considered benign. However, chondrocalcinosis and pancreatitis occur in some adults.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
153.0 TPM
Cérebro - Hemisfério cerebelar
140.5 TPM
Testículo
104.7 TPM
Esôfago - Muscular
97.3 TPM
Fallopian Tube
94.3 TPM
OUTRAS DOENÇAS (8)
autosomal dominant hypocalcemia 2familial hypocalciuric hypercalcemia 2anastomosing haemangiomauveal melanoma
HGNC:4379UniProt:P29992

Variantes genéticas (ClinVar)

99 variantes patogênicas registradas no ClinVar.

🧬 GNA11: NM_002067.5(GNA11):c.548G>C (p.Arg183Pro) ()
🧬 GNA11: NM_002067.5(GNA11):c.535G>A (p.Val179Met) ()
🧬 GNA11: NM_002067.5(GNA11):c.980A>G (p.His327Arg) ()
🧬 GNA11: NM_002067.5(GNA11):c.548G>A (p.Arg183His) ()
🧬 GNA11: NM_002067.5(GNA11):c.542G>C (p.Arg181Pro) ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Facomatose pigmento-vascular

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
57 papers (10 anos)
#1

Retrospective study of photodynamic therapy for the GNA-Related Capillary Malformation spectrum of pediatric patients.

Photodiagnosis and photodynamic therapy2026 Mar 19

Vascular malformations caused by GNAQ/GNA11 somatic mutations are related to capillary malformations (CM), which include port-wine stains (PWS), and also include capillary malformation-related syndromes, such as Sturge-Weber syndrome (SWS), capillary malformation with overgrowth (CMO), diffuse capillary malformation with overgrowth (DCMO), and phakomatosis pigmentovascularis (PPV). These disorders are known as the GNA-Related Capillary malformation spectrum (GNARCMs). This spectrum presents a therapeutic challenge. This study aimed to evaluate the efficacy and safety of photodynamic therapy (PDT) for treating the GNARCMs of pediatric patients. The clinical manifestations of the pediatric GNARCMs patients were retrospectively analyzed, and the treatment data were assessed after undergoing PDT mediated with a combination of Hemoporfin and 532-nm light. For evaluation of improvement, photographs taken before and after photodynamic therapy were evaluated by three independent assessors blindly. Patient satisfaction was also used as a factor in the efficacy evaluation. Adverse events were recorded after treatment. We identified 25 pediatric patients in the study, including 11 patients of SWS, 8 patients of PPV, 5 patients of CMO, and 1 patient of DCMO. After an average of 1.64 sessions of PDT, based on the overall visual assessment, 72% of patients responded to treatment (with >25% color blanching), 48% of patients showed excellent or good levels of improvement (with >50% color blanching). Most adverse events were transient and self-limiting, except one patient of SWS, on the third day after PDT, the visual acuity of the eye on the non-treated side suddenly decreased, and the patient was diagnosed with retinal detachment, which was considered to be related to primary glaucoma rather than PDT. Focusing on the various clinical manifestations of the GNARCMs, after except contraindications, PDT can be selected for treatment of pediatric patients, and its effectiveness and safety are worthy of affirmation.

#2

An Infant With Phakomatosis Pigmentovascularis Complicated by Multisystem Damage: Elaborate Care Leads to a Positive Outcome.

Clinical case reports2026 Mar

This report highlights the value of multidisciplinary collaboration, personalized care, dynamic monitoring of seizure activity, and innovative skin management in a 2-month-old with Phakomatosis Pigmentovascularis. In parallel, the nursing team implemented a multidimensional "medical-social-psychological" support model, providing psychological guidance and economic assistance to the family to help the infant achieve a favorable outcome.

#3

Phakomatosis pigmentovascularis presenting with ischaemic stroke.

BMJ case reports2025 Jul 31

A woman in her late 40s presented to the emergency department with a sudden onset of left hemiparesis and left hemihypesthesia. Neurological examination revealed decreased muscle strength and decreased pinprick sensation over her left-sided body. CT and MRI of the brain demonstrated evidence of acute infarction involving the right centrum semiovale and the superior part of the right corona radiata. CT angiography of the brain and neck revealed no atherosclerotic changes or significant stenosis in the large intracranial and extracranial arteries. The National Institutes of Health Stroke Scale was 3. She was diagnosed with acute ischaemic stroke and admitted to the stroke unit. Dual antiplatelets were initially prescribed according to the CHANCE study. Concurrently, she exhibited characteristic cutaneous manifestations of dermal melanosis over both cheeks and forehead with port-wine stain over her face and upper trunk, prompting suspicion of phakomatosis pigmentovascularis type IIb. After the completion of standard ischaemic stroke treatment, she has recovered and is currently under the outpatient follow-up.

#4

Clinical Insights Into a Large Cohort of Phakomatosis Pigmentovascularis.

Journal of glaucoma2025 Jun 01

Phakomatosis pigmentovascularis, a multisystem disorder, exhibited male predominance, with Phakomatosis cesioflammea as the most prevalent type. Glaucoma affected 88% of eyes, with three-quarters requiring surgery. Systemic issues, notably epilepsy and anemia, were prevalent in over half of all subjects. To report the clinical profile and demographic characteristics of a large cohort with Phakomatosis pigmentovascularis (PPV). Included 119 eyes of 60 patients with PPV between January 1996 and January 2023 (27 y). This is a retrospective multicentric study involving 4 tertiary network institutes in India. The diagnosis of PPV was established based on the concurrent presence of pigmentary nevi and capillary malformation, with classification conducted according to the Happle classification system. Demographic information, clinical features at the time of diagnosis (both ocular and systemic), the prevalence of glaucoma, details of management strategies used, and the subsequent outcomes were meticulously documented. Key outcome measures included the prevalence of glaucoma among patients, the frequency of systemic abnormalities noted, and the various surgical interventions performed along with their respective success rates. The cohort had male preponderance (male: female ratio of 67%:33%), with median age of presentation at 0.48 (range=0.12, 7.77) years. Glaucoma was observed in 105 eyes (88.2%), with bilateral involvement present in 75% of cases. The most prevalent phenotype observed within the cohort was Phakomatosis cesioflammea (Type iib), affecting 65% of patients. Systemic abnormalities were noted in 51.6% of cases, with epilepsy (45%) and anemia (36%) being the most frequently documented conditions. Surgical intervention was required for 64.7% of eyes for intraocular pressure control, with combined trabeculotomy and trabeculectomy being the predominant procedure used. Surgical success was noted in 87% of eyes, and 19.4% eyes had complications. Phakomatosis cesioflammea (Type iib) was the most common subgroup noted. The majority of patients had glaucoma, often bilateral, with two-thirds requiring surgical intervention for IOP control. Systemic abnormalities were common, emphasizing the need for comprehensive multisystem evaluation in these patients.

#5

Phakomatosis pigmentovascularis type 2a: a rare case report.

AME case reports2025

Phakomatosis pigmentovascularis (PPV) is a rare congenital cutaneous syndrome characterized by capillary malformation and extensive dermal melanosis. The complexity of PPV is reflected in its evolving classification systems. Systemic manifestations encompass ocular, neurological, vascular, musculoskeletal, and renal involvement. The pathogenesis, linked to abnormalities in neural cell development and migration, contributes to the varied clinical features of PPV. We describe a rare case of a 21-month-old Saudi girl who presented to our clinic with features of PPV type 2a. A 21-month-old Saudi girl presented to the clinic with erythematous to violaceous patches and diffuse greyish patches over her back and buttocks since birth. Examination revealed port-wine stains, extensive Mongolian spots, and a slight lower limb length discrepancy. The mother reported a single febrile seizure episode previously. The patient underwent an ophthalmological examination where the overall impression was unremarkable. She was referred to Pediatric Neurology for further investigation. PPV manifests through the simultaneous presence of vascular and melanocytic components. The classification of PPV has evolved over time, incorporating additional types and simplified groupings. Our case aligns with PPV type 2a and underscores the necessity for investigations considering potential systemic complications. Despite the generally benign course of PPV, tailored interventions, such as laser therapy, prove valuable for cosmetic improvement. The importance of regular follow-ups and collaboration among medical specialties, especially in Neurology, Ophthalmology, and Vascular surgery, is necessary for comprehensive care of individuals with PPV.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC91 artigos no totalmostrando 56

2026

Retrospective study of photodynamic therapy for the GNA-Related Capillary Malformation spectrum of pediatric patients.

Photodiagnosis and photodynamic therapy
2026

An Infant With Phakomatosis Pigmentovascularis Complicated by Multisystem Damage: Elaborate Care Leads to a Positive Outcome.

Clinical case reports
2025

Phakomatosis pigmentovascularis with cavernous transformation of the portal vein.

Indian journal of dermatology, venereology and leprology
2025

Phakomatosis pigmentovascularis presenting with ischaemic stroke.

BMJ case reports
2025

Clinical Insights Into a Large Cohort of Phakomatosis Pigmentovascularis.

Journal of glaucoma
2025

Phakomatosis pigmentovascularis type 2a: a rare case report.

AME case reports
2024

Somatic GNA11/GNAQ variants in a cohort of Chinese children with phakomatosis pigmentovascularis.

Pediatric investigation
2024

Photodynamic therapy for the treatment of port-wine stains in phakomatosis pigmentovascularis.

Journal of cosmetic dermatology
2023

Phakomatosis Pigmentovascularis: A Rare Disease.

The Journal of the Association of Physicians of India
2024

GNAQ/GNA11 Mosaicism Is Associated with Abnormal Serum Calcium Indices and Microvascular Neurocalcification.

The Journal of investigative dermatology
2023

Verification of the efficacy of topical sirolimus gel for systemic rare vascular malformations: a pilot study.

The Journal of dermatology
2024

Retinal vascular abnormalities in a case of phakomatosis pigmentovascularis.

Clinical &amp; experimental optometry
2022

Phakomatosis Pigmentovascularis with Atypical Sturge-Weber Syndrome, Glaucoma and Asymptomatic CNS Microcirculation Aberrations.

Indian journal of dermatology
2023

PTPN11 Mosaicism Causes a Spectrum of Pigmentary and Vascular Neurocutaneous Disorders and Predisposes to Melanoma.

The Journal of investigative dermatology
2023

Outcomes of Microcatheter-Assisted Trabeculotomy for Glaucoma Associated With Sturge-Weber Syndrome and Phakomatosis Pigmentovascularis.

American journal of ophthalmology
2022

Early-onset hypertension associated with extensive cutaneous capillary malformations harboring postzygotic variants in GNAQ and GNA11.

Pediatric dermatology
2022

Ocular features in a patient presenting with a rare combination of multiple phakomatoses.

BMJ case reports
2022

Phakomatosis pigmentovascularis type IIb with Klippel-Trenaunay syndrome: Association with GNAQ mutation in vascular endothelial cells.

The Journal of dermatology
2022

Phakomatosis pigmentovascularis type Ⅲa mainly manifested by zosteriform nevus spilus: A case report with dermoscopic features.

Photodiagnosis and photodynamic therapy
2022

Bilateral Phakomatosis Cesiomarmorata With Ocular Melanocytosis and Secondary Glaucoma.

Cureus
2022

Mosaic GNA11 mutations and a second hit in KRAS in phakomatosis pigmentovascularis are associated with intraosseous arteriovenous malformations in the jaw.

Journal of the European Academy of Dermatology and Venereology : JEADV
2022

Dermoscopic features of Phakomatosis pigmentovascularis type II: An underutilized tool!

Journal of cosmetic dermatology
2022

Hematoporphyrin monomethyl ether-mediated photodynamic therapy for phakomatosis pigmentovascularis type Ⅱ: A case report.

Photodiagnosis and photodynamic therapy
2021

Phakomatosis Pigmentovascularis.

Ophthalmology. Glaucoma
2023

CHOROIDAL MELANOMA IN PHAKOMATOSIS PIGMENTOVASCULARIS WITH OVERLAPPING STURGE-WEBER SYNDROME AND KLIPPEL-TRENAUNAY SYNDROME.

Retinal cases &amp; brief reports
2021

Hematoporphyrin monomethyl ether-mediated photodynamic therapy temporarily relieves severe pruritis from phakomatosis pigmentovascularis: A case report.

Photodiagnosis and photodynamic therapy
2021

Phakomatosis pigmentovascularis IIb (phakomatosis cesioflammea) associated with the absence of infrarenal inferior vena cava.

International journal of dermatology
2021

Ocular manifestations in phakomatosis pigmentovascularis: Current concepts on pathogenesis, diagnosis, and management.

Survey of ophthalmology
2020

Early-Onset Glaucoma Manifesting as Buphthalmos in an Infant with Phakomatosis Pigmentovascularis Type IIa.

Ophthalmology. Glaucoma
2021

Ocular manifestations of facial port-wine stain, nevus of Ota, and phakomatosis pigmentovascularis in Asian patients.

Journal of the American Academy of Dermatology
2020

Congenital Triangular Alopecia Associated with Phakomatosis Pigmentovascularis Type II along with Klippel Trenaunay Syndrome.

Indian dermatology online journal
2019

Phakomatosis pigmentovascularis type IIb.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
2019

A rare case of phakomatosis pigmentovascularis type IIb associated with inverse Klippel-Trenaunay syndrome and Sturge-Weber syndrome.

Indian journal of dermatology, venereology and leprology
2019

Retinal Vascular Abnormalities in Phakomatosis Pigmentovascularis.

Ophthalmology. Retina
2019

Clinical characteristics and treatment of 52 cases of phakomatosis pigmentovascularis.

The Journal of dermatology
2019

Phakomatosis Pigmentovascularis: A Clinical Profile of 11 Indian Patients.

Indian journal of dermatology
2019

Oral healthcare management of a child with phakomatosis pigmentovascularis associated with bilateral Sturge-Weber syndrome.

Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry
2018

A comprehensive review of Mongolian spots with an update on atypical presentations.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2018

Port-wine stain as a clue for two rare coexisting entities.

BMJ case reports
2019

Pathophysiology and management of glaucoma associated with phakomatoses.

Journal of neuroscience research
2018

[Phakomatosis pigmentovascularis cesioflammea: a case report].

Archivos argentinos de pediatria
2018

Outcomes of Infantile-Onset Glaucoma Associated With Port Wine Birthmarks and Other Periocular Cutaneous Vascular Malformation.

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
2018

CHOROIDAL MELANOMA IN PHAKOMATOSIS PIGMENTOVASCULARIS WITH KLIPPEL-TRENAUNAY SYNDROME.

Retina (Philadelphia, Pa.)
2017

An unusual case of phakomatosis pigmentovascularis type IIb with Becker's nevus.

European journal of dermatology : EJD
2016

Genetic basis for vascular anomalies.

Seminars in cutaneous medicine and surgery
2017

Phakomatosis pigmentovascularis type IIb: A case with Klippel-Trenáunay syndrome and extensive dermal melanocytosis as nevus of Ota, nevus of Ito and ectopic Mongolian spots.

The Journal of dermatology
2016

A case of phakomatosis pigmentovascularis type II: port-wine stain and dermal melanocytosis with cutis marmorata telangiectatica congenita-like lesions.

European journal of dermatology : EJD
2016

Mosaic Activating Mutations in GNA11 and GNAQ Are Associated with Phakomatosis Pigmentovascularis and Extensive Dermal Melanocytosis.

The Journal of investigative dermatology
2015

Phakomatosis pigmentovascularis Type IIb, Sturge-Weber syndrome and cone shaped tongue: An unusual association.

Indian journal of dermatology, venereology and leprology
2015

Ophthalmic Alterations in the Sturge-Weber Syndrome, Klippel-Trenaunay Syndrome, and the Phakomatosis Pigmentovascularis: An Independent Group of Conditions?

BioMed research international
2015

Rare Diseases Leading to Childhood Glaucoma: Epidemiology, Pathophysiogenesis, and Management.

BioMed research international
2015

Congenital Triangular Alopecia.

International journal of trichology
2015

Phakomatosis Pigmentovascularis Associated With Sturge-Weber Syndrome, Ota Nevus, and Congenital Glaucoma.

Medicine
2015

Unusual case of phakomatosis pigmentovascularis in a Japanese female infant associated with three phakomatoses: Port-wine stain, dermal melanocytosis and cutis marmorata telangiectatica congenita.

The Journal of dermatology
2015

Bilateral Sturge-Weber and Phakomatosis Pigmentovascularis with Glaucoma, an Overlap Syndrome.

Case reports in ophthalmological medicine
2015

Phakomatosis pigmentovascularis presenting with sturge-weber syndrome and klippel-trenaunay syndrome.

Indian journal of dermatology
Ver todos os 91 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Facomatose pigmento-vascular.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Facomatose pigmento-vascular

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Retrospective study of photodynamic therapy for the GNA-Related Capillary Malformation spectrum of pediatric patients.
    Photodiagnosis and photodynamic therapy· 2026· PMID 41864397mais citado
  2. An Infant With Phakomatosis Pigmentovascularis Complicated by Multisystem Damage: Elaborate Care Leads to a Positive Outcome.
    Clinical case reports· 2026· PMID 41810224mais citado
  3. Phakomatosis pigmentovascularis presenting with ischaemic stroke.
    BMJ case reports· 2025· PMID 40744635mais citado
  4. Clinical Insights Into a Large Cohort of Phakomatosis Pigmentovascularis.
    Journal of glaucoma· 2025· PMID 39950872mais citado
  5. Phakomatosis pigmentovascularis type 2a: a rare case report.
    AME case reports· 2025· PMID 39866269mais citado
  6. Using selective laser trabeculoplasty to manage glaucoma in a child with phakomatosis pigmentovascularis.
    Am J Ophthalmol Case Rep· 2026· PMID 41890785recente
  7. Phakomatosis pigmentovascularis with cavernous transformation of the portal vein.
    Indian J Dermatol Venereol Leprol· 2025· PMID 41100395recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:2875(Orphanet)
  2. MONDO:0017318(MONDO)
  3. GARD:4312(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q7180213(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Facomatose pigmento-vascular
Compêndio · Raras BR

Facomatose pigmento-vascular

ORPHA:2875 · MONDO:0017318
Prevalência
<1 / 1 000 000
Casos
248 casos conhecidos
Herança
Not applicable
CID-10
Q85.8 · Outras facomatoses não classificadas em outra parte
CID-11
Início
Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C1274879
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades